![]() |
|
|
Vol. 295, Issue 2, 463-473, November 2000
Central Research Division, Pfizer Inc., Groton, Connecticut
Future alternatives to the presently accepted in vitro paradigm of
prediction of intrinsic clearance, which could be used earlier in the
drug discovery process, would potentially accelerate efforts to
identify better drug candidates with more favorable metabolic profiles
and less likelihood of failure with regard to human pharmacokinetic
attributes. In this study we describe two computational methods for
modeling human microsomal and hepatocyte intrinsic clearance data
derived from our laboratory and the literature, which utilize
pharmacophore features or descriptors derived from molecular structure.
Human microsomal intrinsic clearance data generated for 26 known
therapeutic drugs were used to build computational models using
commercially available software (Catalyst and
Cerius2), after first converting the data to
hepatocyte intrinsic clearance. The best Catalyst pharmacophore model
gave an r of 0.77 for the observed versus predicted
clearance. This pharmacophore was described by one hydrogen bond
acceptor, two hydrophobic features, and one ring aromatic feature
essential to discriminate between high and low intrinsic clearance. The
Cerius2 quantitative structure activity relationship (QSAR)
model gave an r2 = 0.68 for the
observed versus predicted clearance and a cross-validated r2 (q2) of 0.42. Similarly, literature data for human hepatocyte intrinsic clearance for
18 therapeutic drugs were also used to generate two separate models
using the same computational approaches. The best Catalyst
pharmacophore model gave an improved r of 0.87 and was
described by two hydrogen bond acceptors, one hydrophobe, and 1 positive ionizable feature. The Cerius2 QSAR gave an
r2 of 0.88 and a
q2 of 0.79. Each of these models was then
used as a test set for prediction of the intrinsic clearance data in
the other data set, with variable successes. These present models
represent a preliminary application of QSAR software to modeling and
prediction of human in vitro intrinsic clearance.
This article has been cited by other articles:
![]() |
D. Bednarczyk, S. Ekins, J. H. Wikel, and S. H. Wright Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1 Mol. Pharmacol., March 1, 2003; 63(3): 489 - 498. [Abstract] [Full Text] [PDF] |
||||